Single-cell transcriptomics of hepatic stellate cells uncover crucial pathways and key regulators involved in non-alcoholic steatohepatitis
Background: Fibrosis is an important pathological process in the development of non-alcoholic steatohepatitis (NASH), and the activation of hepatic stellate cell (HSC) is a central event in liver fibrosis. However, the transcriptomic change of activated HSCs (aHSCs) and resting HSCs (rHSCs) in NASH...
Main Authors: | Weiwei He, Caoxin Huang, Xiulin Shi, Menghua Wu, Han Li, Qiuhong Liu, Xiaofang Zhang, Yan Zhao, Xuejun Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Bioscientifica
2023-01-01
|
Series: | Endocrine Connections |
Subjects: | |
Online Access: | https://ec.bioscientifica.com/view/journals/ec/12/2/EC-22-0502.xml |
Similar Items
-
Roles of hepatic stellate cells in NAFLD: From the perspective of inflammation and fibrosis
by: Man Wang, et al.
Published: (2022-10-01) -
Pharmaceutical Efficacy of Gypenoside LXXV on Non-Alcoholic Steatohepatitis (NASH)
by: Jin Ha Lee, et al.
Published: (2020-10-01) -
Novel oral SPT inhibitor CH5169356 inhibits hepatic stellate cell activation and ameliorates hepatic fibrosis in mouse models of non‐alcoholic steatohepatitis (NASH)
by: Natsuko Hada, et al.
Published: (2023-06-01) -
Butyrate Protects against Diet-Induced NASH and Liver Fibrosis and Suppresses Specific Non-Canonical TGF-β Signaling Pathways in Human Hepatic Stellate Cells
by: Eveline Gart, et al.
Published: (2021-12-01) -
Lactate transporter MCT1 in hepatic stellate cells promotes fibrotic collagen expression in nonalcoholic steatohepatitis
by: Kyounghee Min, et al.
Published: (2024-04-01)